ERS Genomics ERS Genomics Licenses CRISPR-Cas9 IP to Sumitomo Pharma The nonexclusive licensing agreement with the Japanese drugmaker marks the 16th such deal ERS Genomics has signed in Japan. ERS Genomics Licenses CRISPR IP to Central Institute for Experimental Animals ERS Genomics was founded to provide access to CRISPR-Cas9 intellectual property held by Emmanuelle Charpentier. People in the News: New Appointments at Centogene, Allelica, ERS Genomics, More ERS Genomics Licenses CRISPR-Cas9 Portfolio to Cellular Engineering Technologies CET said it will integrate its stem cell technology with CRISPR-Cas9 to create next-generation stem cells for life science research. ERS Genomics Licenses CRISPR IP to Japan SLC Japan SLC, a biotechnology company providing animal models to the research community, will use the license to expand its offerings. Jun 7, 2021 ERS Genomics Licenses CRISPR IP to GenOway May 12, 2021 ERS Genomics Licenses CRISPR Patents to GenScript Biotech Apr 19, 2021 ERS Genomics Licenses CRISPR Patents to Nuvisan Mar 10, 2021 ERS Genomics Licenses CRISPR Patents to Setsuro Tech Mar 5, 2021 People in the News: New Appointments at Precipio, ERS Genomics, Omniome, PierianDx, More Mar 3, 2021 ERS Genomics Licenses CRISPR Patents to Otsuka Pharmaceutical Feb 23, 2021 ERS Genomics Licenses CRISPR Patents to Korean Biotech Firm G+FLAS Life Sciences Feb 16, 2021 ERS Genomics Licenses CRISPR Patents to CRO ZeClinics Dec 1, 2020 ERS Genomics Licenses CRISPR Patents to German Startup Vivlion Oct 14, 2020 ERS Genomics, FASMAC Sign Deal to Commercialize CRISPR-Cas9 Research Reagents in Japan Sep 15, 2020 ERS Genomics, Applied StemCell Ink Commercialization Agreement for CRISPR Services, Reagents Sep 11, 2020 Patent Board Rules Broad Institute First With Functioning CRISPR System in Eukaryotic Cells Apr 2, 2020 ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam Feb 11, 2020 ERS Genomics Licenses CRISPR-Cas9 Patents to Aelian Biotechnology Feb 10, 2020 European Patent Office Upholds UC Berkeley CRISPR Patent Jan 17, 2020 Revocation of Broad Institute CRISPR Patent Upheld in Europe Jan 13, 2020 ERS Genomics Licenses CRISPR-Cas9 IP to Daiichi Sankyo Jan 7, 2020 ERS Genomics Licenses CRISPR-Cas9 Tools, Reagents to New England Biolabs Jul 31, 2019 CRISPR Patent Pools Pop Up, But Participation Uncertain as IP Holders Continue Legal Battles Premium Jun 4, 2019 ERS Genomics Licenses CRISPR-Cas9 Tech to Bioneer Load More Breaking News Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.